- Home
- PBYI vs CLAR Comparison
PBYI vs CLAR Comparison
Compare PBYI & CLAR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- PBYI
- CLAR
- Stock Information
- Founded
- PBYI 2010
- CLAR 1957
- Country
- PBYI United States
- CLAR United States
- Employees
- PBYI N/A
- CLAR N/A
- Industry
- PBYI Biotechnology: Pharmaceutical Preparations
- CLAR Recreational Games/Products/Toys
- Sector
- PBYI Health Care
- CLAR Consumer Discretionary
- Exchange
- PBYI Nasdaq
- CLAR Nasdaq
- Market Cap
- PBYI 138.4M
- CLAR 150.4M
- IPO Year
- PBYI N/A
- CLAR N/A
- Fundamental
- Price
- PBYI $2.91
- CLAR $3.23
- Analyst Decision
- PBYI Strong Buy
- CLAR Strong Buy
- Analyst Count
- PBYI 1
- CLAR 4
- Target Price
- PBYI $7.00
- CLAR $5.50
- AVG Volume (30 Days)
- PBYI 280.0K
- CLAR 192.8K
- Earning Date
- PBYI 05-08-2025
- CLAR 05-08-2025
- Dividend Yield
- PBYI N/A
- CLAR 3.11%
- EPS Growth
- PBYI 143.51
- CLAR N/A
- EPS
- PBYI 0.77
- CLAR N/A
- Revenue
- PBYI $232,668,000.00
- CLAR $255,437,000.00
- Revenue This Year
- PBYI N/A
- CLAR N/A
- Revenue Next Year
- PBYI N/A
- CLAR $10.96
- P/E Ratio
- PBYI $3.78
- CLAR N/A
- Revenue Growth
- PBYI 2.67
- CLAR N/A
- 52 Week Low
- PBYI $2.23
- CLAR $3.18
- 52 Week High
- PBYI $5.20
- CLAR $7.24
- Technical
- Relative Strength Index (RSI)
- PBYI 44.50
- CLAR 38.74
- Support Level
- PBYI $2.88
- CLAR $3.23
- Resistance Level
- PBYI $3.14
- CLAR $3.55
- Average True Range (ATR)
- PBYI 0.16
- CLAR 0.15
- MACD
- PBYI 0.00
- CLAR 0.03
- Stochastic Oscillator
- PBYI 11.36
- CLAR 18.27
About PBYI Puma Biotechnology Inc
Puma Biotechnology Inc is a biopharmaceutical company that develops and commercializes innovative products to enhance cancer care and improve treatment outcomes for patients. It is currently commercializing NERLYNX, an oral version of neratinib, for the treatment of HER2-positive breast cancer. Also it develops alisertib. Alisertib is a selective, small-molecule inhibitor of aurora kinase A that is designed to disrupt mitosis leading to apoptosis of rapidly proliferating tumor cells that are dependent on aurora kinase A.
About CLAR Clarus Corporation
Clarus Corp is a designer, developer, manufacturer, and distributor of outdoor equipment and lifestyle products focused on the climb, ski, mountain, sport, and skincare markets. The company operates through the Outdoor segment, which includes Black Diamond Equipment and PIEPS, is a world-wide leader in designing, manufacturing, and marketing outdoor engineered equipment and apparel for climbing, mountaineering, trail running, backpacking, skiing, and a wide range of other year-round outdoor recreation activities. The Adventure segment, which includes Rhino-Rack, MAXTRAX and TRED, is a manufacturer of engineered automotive roof racks, trays, mounting systems, luggage boxes, carriers, recovery boards and accessories in Australia and New Zealand and United States.